Asheebo Rojas, PhD

Affiliations: 
Pharmacology Emory University, Atlanta, GA 
Area:
epilepsy
Google:
"Asheebo Rojas"
Mean distance: 14.23 (cluster 6)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Amaradhi R, Banik A, Mohammed S, et al. (2020) Potent, selective, water soluble, brain-permeable EP2 receptor antagonist for use in central nervous system disease models. Journal of Medicinal Chemistry
Rojas A, Banik A, Chen D, et al. (2019) A novel microglia cell line expressing the human EP2 receptor. Acs Chemical Neuroscience
Manji Z, Rojas A, Wang W, et al. (2019) 5xFAD Mice Display Sex-Dependent Inflammatory Gene Induction During the Prodromal Stage of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad
Rojas A, Ganesh T, Wang W, et al. (2019) A rat model of organophosphate-induced status epilepticus and the beneficial effects of EP2 receptor inhibition. Neurobiology of Disease
Rojas A, Chen D, Ganesh T, et al. (2018) The COX-2/prostanoid signaling cascades in seizure disorders. Expert Opinion On Therapeutic Targets
Rojas A, Wang W, Glover A, et al. (2018) Beneficial Outcome of Urethane Treatment Following Status Epilepticus in a Rat Organophosphorus Toxicity Model. Eneuro. 5
Rojas A, Ganesh T, Walker A, et al. (2017) Ethylatropine bromide as a peripherally-restricted muscarinic antagonist. Acs Chemical Neuroscience
Rojas A, Ganesh T, Manji Z, et al. (2016) Inhibition of the prostaglandin E2 receptor EP2 prevents status epilepticus-induced deficits in the novel object recognition task in rats. Neuropharmacology
Rojas A, Ganesh T, Lelutiu N, et al. (2015) Inhibition of the prostaglandin EP2 receptor is neuroprotective and accelerates functional recovery in a rat model of organophosphorus induced status epilepticus. Neuropharmacology. 93: 15-27
Rojas A, Gueorguieva P, Lelutiu N, et al. (2014) The prostaglandin EP1 receptor potentiates kainate receptor activation via a protein kinase C pathway and exacerbates status epilepticus. Neurobiology of Disease. 70: 74-89
See more...